Solventum Corp
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 |
|---|---|---|---|---|
| Revenue | $8.3B | $8.3B | $8.2B | $8.1B |
| Gross profit | $4.5B | $4.6B | $4.7B | $4.7B |
| Operating income | $2.2B | $1.0B | $1.7B | $1.7B |
| Cash from operations | $369.0M | $1.2B | $1.9B | $1.7B |
| Capital expenditure | $379.0M | $380.0M | $290.0M | $251.0M |
| Free cash flow | -$10.0M | $805.0M | $1.6B | $1.4B |
| Impairments | $0 | — | — | — |
| Total assets | $14.3B | $14.5B | $13.9B | — |
| Total liabilities | $9.2B | $11.5B | $2.3B | — |
| Total debt | $5.1B | $8.1B | — | — |
Shares outstanding 173.2M · Free float 85.1%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.